Free Trial
NASDAQ:GRAL

Grail (GRAL) Stock Price, News & Analysis

$14.92
-0.06 (-0.40%)
(As of 08/27/2024 ET)
Today's Range
$14.81
$15.23
50-Day Range
N/A
52-Week Range
$12.51
$23.36
Volume
617,778 shs
Average Volume
1.48 million shs
Market Capitalization
$463.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRAL stock logo

About Grail Stock (NASDAQ:GRAL)

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

GRAL Stock Price History

GRAL Stock News Headlines

Holy grail of giggles
Forget the Polls, Here’s What Will Happen this Election
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
Hawaii-style taro donuts with Holey Grail Donuts
Golden Grail Beverages Announces New Business Strategy
Forget the Polls, Here’s What Will Happen this Election
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
Grail to shed 350 workers in restructuring
See More Headlines
Receive GRAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
8/27/2024
Next Earnings (Estimated)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GRAL
Previous Symbol
NASDAQ:GRAL
Web
N/A
Fax
N/A
Employees
1,360
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$109.74 million

Miscellaneous

Free Float
N/A
Market Cap
$463.31 million
Optionable
Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Robert P. Ragusa (Age 64)
    CEO & Director
    Comp: $1.48M
  • Dr. Joshua J. Ofman M.D. (Age 59)
    M.S.H.S, President
    Comp: $1.04M
  • Mr. Aaron Freidin
    Chief Financial Officer
  • Mr. Paul Ciccolella
    Senior VP of Global Development & Operations
  • Ms. Amoolya Singh Ph.D.
    Senior VP of Research & Chief Scientific Officer
  • Mr. Abram Barth J.D.
    M.P.H., General Counsel
  • Ms. Julie Currie
    Chief People Officer
  • Mr. Rodger Currie
    VP and Head of Government Affairs & Alliance Development
  • Sir Harpal S. Kumar M.A.
    M.B.A., MA, MBA, MEng, President Biopharma Business & Europe
  • Dr. Satnam Alag Ph.D.
    Senior VP of Software Engineering & Chief Security Officer

GRAL Stock Analysis - Frequently Asked Questions

How have GRAL shares performed this year?

Grail's stock was trading at $14.57 on January 1st, 2024. Since then, GRAL shares have increased by 2.4% and is now trading at $14.92.
View the best growth stocks for 2024 here
.

How do I buy shares of Grail?

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRAL) was last updated on 8/28/2024 by MarketBeat.com Staff

From Our Partners